Clinical Trials
Sep 25, 2026 · 1 min read · 62,403 views
Eli Lilly invests in startup Abridge for clinical trial recruitment
E
Ethan Cole
Editorial · Sep 25, 2026
Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences. The investment, made through
← Previous
Iambic releases next version of its Enchant model, signs deal with AbbVie
Next →
Post-Hoc Live: The China Biotech Debate goes to Washington
